Invivo’s DynaTRIM system is the first commercially available, fully magnetic resonance imaging (MRI)-compatible interventional device for transrectal interventional MRI of the prostate gland.
Pairing DynaCAD for Prostate with DynaTRIM enables a physician to conduct targeted MRI interventions of suspicious areas within the prostate gland, reducing the number of cores acquired during biopsy.
For more information: www.invivocorp.com
July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...
July 25, 2024 
July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...
July 24, 2024 
July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...
July 23, 2024 
July 23, 2024 — Researchers at the National Institutes of Health (NIH) found that an artificial intelligence (AI) model ...
July 23, 2024 
July 17, 2024 — Hyperfine, a groundbreaking medical device company that has redefined brain imaging with the world’s ...
July 17, 2024 
July 11, 2024 — GE HealthCare’s MIM Software, a global provider of medical imaging analysis and artificial intelligence ...
July 11, 2024 
July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...
July 02, 2024 
June 27, 2024 — Prenuvo, which makes whole-body MRI screening for early cancer detection and other diseases, has ...
June 27, 2024 
June 25, 2024 — Rady Children’s Hospital-San Diego, one of the nation’s top pediatric health care systems, today ...
June 25, 2024 
June 17, 2024 — Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care ...
June 17, 2024